GlassScriptPhysician profile
David L Sheppard
NPI 1871589440
$17,590.40
in general payments reported to CMS, 2019-2025
51 companies · $2,680 in 2025
The $2,680 reported for 2025 was more than what 95% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,876 · 2020: $1,600 · 2021: $2,846 · 2022: $2,492 · 2023: $2,834 · 2024: $3,262 · 2025: $2,680.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,776.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,776.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $4,500.29 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $1,692.88 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Lilly USA, LLC | $1,467.34 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Amgen INC. | $1,193.05 | 2019-2025 | Evenity, Prolia, Repatha |
| Pfizer INC. | $987.78 | 2019-2025 | |
| Amarin Pharma, INC. | $902.62 | 2019-2023 | |
| Abbvie INC. | $878.45 | 2021-2025 | Ubrelvy, Linzess, Synthroid |
| Astellas Pharma US INC | $835.92 | 2019-2025 | Veozah, Myrbetriq |
| Janssen Pharmaceuticals, INC | $621.17 | 2019-2025 | Spravato |
| Glaxosmithkline, LLC. | $601.39 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $433.42 | 2021-2025 | Jardiance |
| Dexcom, INC. | $376.34 | 2022-2025 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $322.36 | 2023-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $280.53 | 2020-2025 | Trintellix |
| Esperion Therapeutics, INC. | $225.11 | 2021-2025 | Nexletol |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $194.35 | 2021-2025 | Freestyle Libre 3 |
| Biohaven Pharmaceutical Holding Company LTD. | $186.62 | 2022 | |
| Exact Sciences Corporation | $172.13 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $152.44 | 2019-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $149.85 | 2019-2025 | Xifaxan, Trulance |
| Sumitomo Pharma America, INC. | $117.23 | 2023-2025 | Gemtesa |
| Boston Scientific Corporation | $114.65 | 2022-2024 | Watchman Flx, Watchman Access System |
| Sanofi Pasteur INC. | $105.66 | 2019-2025 | |
| Xeris Pharmaceuticals, INC. | $85.58 | 2024-2025 | Gvoke Hypopen |
| Allergan, INC. | $83.37 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $69.97 | 2021 | |
| Merck Sharp & Dohme LLC | $67.16 | 2019-2021 | |
| Avanir Pharmaceuticals, INC. | $62.34 | 2019 | |
| Novartis Pharmaceuticals Corporation | $59.46 | 2019-2021 | |
| Currax Pharmaceuticals LLC | $59.15 | 2022-2023 | Contrave, Nexletol, Nexlizet |
| Nestle Healthcare Nutrition INC. | $57.53 | 2022-2023 | |
| E.R. Squibb & Sons, L.L.C. | $55.48 | 2023-2024 | Eliquis, Camzyos |
| Kowa Pharmaceuticals America, INC. | $50.92 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $46.97 | 2023-2025 | Rexulti |
| Biosense Webster, INC. | $40.18 | 2024 | Carto 3 |
| Nevro Corp. | $36.09 | 2022 | |
| Ethicon INC. | $34.43 | 2020 | |
| Genentech USA, INC. | $33.20 | 2019-2022 | |
| Insmed, INC. | $27.32 | 2025 | Arikayce |
| Alexion Pharmaceuticals, INC. | $22.66 | 2024 | Ultomiris |
| Si-Bone, INC. | $22.28 | 2022 | |
| Edwards Lifesciences Corporation | $22.09 | 2025 | |
| Sunovion Pharmaceuticals INC. | $21.29 | 2022 | |
| Eisai INC. | $19.77 | 2025 | |
| Lundbeck LLC | $17.46 | 2024 | Rexulti |
| Corcept Therapeutics | $15.05 | 2025 | Korlym |
| Axsome Therapeutics, INC. | $14.90 | 2025 | Symbravo |
| Arbor Pharmaceuticals, INC. | $14.44 | 2019 | |
| Ibsa Pharma INC. | $13.64 | 2023 | Tirosint, Licart |
| Radius Health, INC. | $13.23 | 2019 | |
| Biogen, INC. | $12.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Sheppard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.